Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double-blind, Parallel-Group, Virtual Study to Evaluate the Effectiveness and Safety of Two Digital Therapeutics in Late Adolescents and Adults for the Prevention of Episodic Migraine

NCT05853900 is registered in ClinicalTrials.gov with Click Therapeutics, Inc. as lead sponsor.

NCT NCT05853900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05853900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double-blind, Parallel-Group, Virtual Study to Evaluate the Effectiveness and Safety of Two Digital Therapeutics in Late Adolescents and Adults for the Prevention of Episodic Migraine
Lead sponsor
Click Therapeutics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
March 28, 2023
Completion date
May 7, 2024
Enrollment
568 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

episodic migraine, headache, headache, migraine, migraine